Activation of the prodrug 4-iodo-3-nitrobenzamide critically depends on the cellular reducing system specific to cancer cells. In non-malignant cells, reduction of this prodrug to the non-toxic amine occurs by the flavoprotein of complex?I of mitochondria receiving Mg2+-ATP-dependent reducing equivalents from NADH to NADPH via pyridine nucleotide transhydrogenation. This hydride transfer is deficient in malignant cells; therefore, the lethal synthesis of 4-iodo-3-nitrosobenzamide takes place selectively. Enzymatic evidence for this mechanism has been provided by cellular studies with lysolecithin-permeabilized cells and cell fractions, which have identified the defect in transhydrogenation in neoplastic cells to be located at the energy transfer site. Confirming previous results, the present study demonstrates the validity of the selective tumoricidal action of the prodrug in cell cultures.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3892/mmr_00000165 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Bendamustine-rituximab elicits dual tumoricidal and immunomodulatory responses via cGAS-STING activation in diffuse large B-cell lymphoma.
J Immunother Cancer
November 2024
Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China
Article Synopsis
- Bendamustine-rituximab (BR) therapy shows effectiveness in treating elderly patients with diffuse large B-cell lymphoma (DLBCL), especially when other treatments are unsuitable.
- The study investigates the mechanisms of BR therapy through various methods, including RNA sequencing and Crispr technology, revealing that BR not only kills tumor cells by causing apoptosis but also activates the immune system via the cGAS-STING pathway.
- The findings indicate that BR creates an inflammatory tumor environment, suggesting that combining BR with other therapies could enhance treatment outcomes for patients with DLBCL.
Cabergoline targets multiple pathways to inhibit PRL secretion and increases stromal fibrosis.
Eur J Endocrinol
June 2024
Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
Objective: Unravel the potential mechanism(s) of the on- and off-target actions of dopamine agonist therapy in both human prolactinoma tumors and neighboring stromal and immune cells.
Design And Methods: Five surgically resected prolactinomas (PRLomas) from 3 cabergoline (CBG)-treated patients and 2 treatment-naive patients were analyzed by using single-cell RNA sequencing (scRNA-seq) to compare the cellular composition and transcriptional landscape.
Results: Six major cell populations, namely tumor (88.
Redundant tumor microenvironment (TME) immunosuppressive mechanisms and epigenetic maintenance of terminal T cell exhaustion greatly hinder functional antitumor immune responses in chronic lymphocytic leukemia (CLL). Bromodomain and extraterminal (BET) proteins regulate key pathways contributing to CLL pathogenesis and TME interactions, including T cell function and differentiation. Herein, we report that blocking BET protein function alleviates immunosuppressive networks in the CLL TME and repairs inherent CLL T cell defects.
View Article and Find Full Text PDF(Pentamethylcyclopentadienyl)chloridoiridium(III) Complex Bearing Bidentate PhPCHCHSPh-κ,κ Ligand.
Biomolecules
March 2024
Department of Engineering and Natural Sciences, University of Applied Sciences Merseburg, Eberhard-Leibnitz-Strasse 2, D-06217 Merseburg, Germany.
The (pentamethylcyclopentadienyl)chloridoiridium(III) complex bearing a κ,κ-bonded PhPCHCHSPh ligand ([Ir(η-CMe)Cl(PhP(CH)SPh-κκ)]PF, ()] was synthesized and characterized. Multinuclear (H, C and P) NMR spectroscopy was employed for the determination of the structure. Moreover, SC-XRD confirmed the proposed structure belongs to the "piano stool" type.
View Article and Find Full Text PDFA Bacterial and Ganglioside-based Nanoparticle Initiates Reprogramming of Macrophages and Promotes Antitumor Phenotypes.
J Immunol
February 2024
Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY.
Macrophages represent the most abundant immune component of the tumor microenvironment and often exhibit protumorigenic (M2-like) phenotypes that contribute to disease progression. Despite their generally accepted protumorigenic role, macrophages can also display tumoricidal (or M1-like) behavior, revealing that macrophages can be functionally reprogrammed, depending on the cues received within the tumor microenvironment. Moreover, such plasticity may be achieved by pharmacologic or biologic interventions.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!